{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T21:45:39Z","timestamp":1764020739300},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T00:00:00Z","timestamp":1697846400000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The immortality of cancer cells relies on maintaining the length of telomeres, which prevents cellular senescence and enables unlimited replication. However, little is currently known about telomerase activity and the alternative lengthening of telomeres (ALT) in vestibular schwannomas. In this study we aimed to elucidate the role that telomerase and ALTs play in vestibular schwannomas.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To address this gap, we conducted a study where we used the gene set variation analysis algorithm with bulk RNA-seq and single-cell RNA-seq to identify the characteristics of each group of patients with vestibular schwannomas, based on their telomere maintenance mechanism subtype.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our findings suggest that patients with relatively high ALT-like groups have a better prognosis than those with relatively high telomerase groups. Specifically, we found that the high telomerase group had relatively higher antigen-presenting cell (APC) activity than the high ALT like group. At the single-cell level, microglia, neutrophils, and fibroblasts showed high telomerase activity and relatively high APC activity compared to other cell types. In addition, Schwann cells in the group with low ALT levels exhibited elevated immune activity at the single-cell level.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These results suggest that personalized drug therapy could be developed from the perspective of precision medicine for patients with relatively high telomerase activity and a high ALT-like group.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11060-023-04458-5","type":"journal-article","created":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T08:02:27Z","timestamp":1697875347000},"page":"113-126","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Telomere maintenance mechanism subtype reveals different immune activity in vestibular schwannoma"],"prefix":"10.1007","volume":"165","author":[{"given":"Ji-Yong","family":"Sung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,21]]},"reference":[{"key":"4458_CR1","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41568-022-00490-1","volume":"22","author":"J Gao","year":"2022","unstructured":"Gao J, Pickett HA (2022) Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies. Nat Rev Cancer 22:515\u2013532","journal-title":"Nat Rev Cancer"},{"key":"4458_CR2","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.3390\/cancers12082207","volume":"12","author":"JY Sung","year":"2020","unstructured":"Sung JY, Lim HW, Joung JG, Park WY (2020) Pan-cancer analysis of alternative lengthening of telomere activity. Cancers (Basel) 12:2207","journal-title":"Cancers (Basel)"},{"key":"4458_CR3","doi-asserted-by":"publisher","first-page":"11101","DOI":"10.3390\/ijms222011101","volume":"22","author":"JY Sung","year":"2021","unstructured":"Sung JY, Cheong JH (2021) Pan-cancer analysis of clinical relevance via telomere maintenance mechanism. Int J Mol Sci 22:11101","journal-title":"Int J Mol Sci"},{"key":"4458_CR4","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.3390\/cells11213342","volume":"11","author":"JY Sung","year":"2022","unstructured":"Sung JY, Cheong JH (2022) Single cell analysis of gastric cancer reveals non-defined telomere maintenance mechanism. Cells 11:3342","journal-title":"Cells"},{"key":"4458_CR5","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12885-019-5424-8","volume":"19","author":"RT Lawlor","year":"2019","unstructured":"Lawlor RT et al (2019) Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis. BMC Cancer 19:232","journal-title":"BMC Cancer"},{"key":"4458_CR6","doi-asserted-by":"publisher","first-page":"e561","DOI":"10.1002\/ctm2.561","volume":"11","author":"JY Sung","year":"2021","unstructured":"Sung JY, Cheong JH (2021) Alternative lengthening of telomeres is mechanistically linked to potential therapeutic vulnerability in the stem-like subtype of gastric cancer. Clin Transl Med 11:e561","journal-title":"Clin Transl Med"},{"key":"4458_CR7","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/modpathol.2015.156","volume":"29","author":"NA Hung","year":"2016","unstructured":"Hung NA et al (2016) Telomere profiles and tumor-associated macrophages with different immune signatures affect prognosis in glioblastoma. Mod Pathol 29:212\u2013226","journal-title":"Mod Pathol"},{"key":"4458_CR8","first-page":"2087","volume":"6","author":"H Liu","year":"2023","unstructured":"Liu H et al (2023) Cancer-associated SMARCAL1 loss-of-function mutations promote alternative lengthening of telomeres and tumorigenesis in telomerase-negative glioblastoma cells. Neuro Oncol 6:2087","journal-title":"Neuro Oncol"},{"key":"4458_CR9","doi-asserted-by":"publisher","first-page":"14676","DOI":"10.1073\/pnas.1512570112","volume":"112","author":"X Gao","year":"2015","unstructured":"Gao X et al (2015) Anti-VEGF treatment improves neurological function and augments radiation response in NF2 schwannoma model. Proc Natl Acad Sci USA 112:14676\u201314681","journal-title":"Proc Natl Acad Sci USA"},{"key":"4458_CR10","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.3390\/cancers14061438","volume":"14","author":"JY Sung","year":"2022","unstructured":"Sung JY, Cheong JH (2022) The matrisome is associated with metabolic reprograming in stem-like phenotypes of gastric cancer. Cancers (Basel) 14:1438","journal-title":"Cancers (Basel)"},{"key":"4458_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2105-4-2","volume":"4","author":"GD Bader","year":"2003","unstructured":"Bader GD, Hogue CW (2003) An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinform 4:2","journal-title":"BMC Bioinform"},{"key":"4458_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann S, Castelo R, Guinney J (2013) GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform 14:7","journal-title":"BMC Bioinform"},{"key":"4458_CR13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ (2017) xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol 18:220","journal-title":"Genome Biol"},{"key":"4458_CR14","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y et al (2019) Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 10:1523","journal-title":"Nat Commun"},{"key":"4458_CR15","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P et al (2018) Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med 24:1550\u20131558","journal-title":"Nat Med"},{"key":"4458_CR16","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.ajpath.2022.06.006","volume":"192","author":"M Xu","year":"2022","unstructured":"Xu M et al (2022) Single-cell RNA-Seq reveals heterogeneity of cell communications between schwann cells and fibroblasts within vestibular schwannoma microenvironment. Am J Pathol 192:1230\u20131249","journal-title":"Am J Pathol"},{"key":"4458_CR17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.stem.2016.05.010","volume":"19","author":"D Grun","year":"2016","unstructured":"Grun D et al (2016) De novo prediction of stem cell identity using single-cell transcriptome data. Cell Stem Cell 19:266\u2013277","journal-title":"Cell Stem Cell"},{"key":"4458_CR18","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/nm1006-1133","volume":"12","author":"EH Blackburn","year":"2006","unstructured":"Blackburn EH, Greider CW, Szostak JW (2006) Telomeres and telomerase: the path from maize, tetrahymena and yeast to human cancer and aging. Nat Med 12:1133\u20131138","journal-title":"Nat Med"},{"key":"4458_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41576-019-0099-1","volume":"20","author":"JW Shay","year":"2019","unstructured":"Shay JW, Wright WE (2019) Telomeres and telomerase: three decades of progress. Nat Rev Genet 20:299\u2013309","journal-title":"Nat Rev Genet"},{"key":"4458_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.trecan.2015.07.007","volume":"1","author":"RL Dilley","year":"2015","unstructured":"Dilley RL, Greenberg RA (2015) Alternative telomere maintenance and cancer. Trends Cancer 1:145\u2013156","journal-title":"Trends Cancer"},{"key":"4458_CR21","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/S0140-6736(03)12681-5","volume":"361","author":"V Hakin-Smith","year":"2003","unstructured":"Hakin-Smith V et al (2003) Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme. Lancet 361:836\u2013838","journal-title":"Lancet"},{"key":"4458_CR22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163449","author":"C Lee-Chang","year":"2023","unstructured":"Lee-Chang C, Lesniak MS (2023) Next-generation antigen-presenting cell immune therapeutics for gliomas. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI163449","journal-title":"J Clin Invest"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04458-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-023-04458-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04458-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T11:11:01Z","timestamp":1699614661000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-023-04458-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["4458"],"URL":"https:\/\/doi.org\/10.1007\/s11060-023-04458-5","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"5 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}